IMC sees opportunities in revised PhRMA Code

Informed Medical Communications, a US provider of peer-to-peer medical forums for the biopharmaceutical industry, issued its position on recent revisions to the Pharmaceutical Research and Manufacturers of America (PhRMA) recent marketing Code Marketletters passim). "IMC remains fully committed to compliance with the PhRMA Code," noted Jaime Nguyen, medical director/compliance officer, adding: "though the guidelines have changed, we have continually monitored the compliance trends so that our services can remain a valuable resource for our clients in reaching their customers."

With the ongoing restrictions on sales representative involvement, IMC (including The Peer Group and RxDialogue) has always proactively evolved its services to maintain the highest level of compliance rigor, enabling their clients a safe option for effectively meeting the needs of their brands. "IMC's medical communications will continue to be one of the few available tactics offering high-impact results for brand teams because its informational presentations and interactive discussions improve patient care and increase exposure to disease states and therapeutic choices," noted Kathleen Bresette, president of The Peer Group. Additionally, IMC's unique use of compliance-trained clinical Moderators ensures a viable, valuable method for supporting biopharmaceutical brands.

Steve Budd, chief executive of IMC commented: "because of this changing regulatory environment, IMC continually scrutinizes the compliance of its services, imbuing in our clients a confidence that IMC medical communications services like our Moderator Advantage Programs (MAPs) and teleconferences will remain an ideal tactic for discussing promotional on-label brand messages with health care professionals."